Correlation Between Alterola Biotech and Bionoid Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Alterola Biotech and Bionoid Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alterola Biotech and Bionoid Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alterola Biotech and Bionoid Pharma, you can compare the effects of market volatilities on Alterola Biotech and Bionoid Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alterola Biotech with a short position of Bionoid Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alterola Biotech and Bionoid Pharma.

Diversification Opportunities for Alterola Biotech and Bionoid Pharma

-0.48
  Correlation Coefficient

Very good diversification

The 3 months correlation between Alterola and Bionoid is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Alterola Biotech and Bionoid Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bionoid Pharma and Alterola Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alterola Biotech are associated (or correlated) with Bionoid Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bionoid Pharma has no effect on the direction of Alterola Biotech i.e., Alterola Biotech and Bionoid Pharma go up and down completely randomly.

Pair Corralation between Alterola Biotech and Bionoid Pharma

Given the investment horizon of 90 days Alterola Biotech is expected to generate 1.73 times less return on investment than Bionoid Pharma. But when comparing it to its historical volatility, Alterola Biotech is 1.66 times less risky than Bionoid Pharma. It trades about 0.06 of its potential returns per unit of risk. Bionoid Pharma is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  100.00  in Bionoid Pharma on November 2, 2024 and sell it today you would lose (72.00) from holding Bionoid Pharma or give up 72.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy99.6%
ValuesDaily Returns

Alterola Biotech  vs.  Bionoid Pharma

 Performance 
       Timeline  
Alterola Biotech 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Alterola Biotech are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Alterola Biotech demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Bionoid Pharma 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Bionoid Pharma are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Bionoid Pharma reported solid returns over the last few months and may actually be approaching a breakup point.

Alterola Biotech and Bionoid Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Alterola Biotech and Bionoid Pharma

The main advantage of trading using opposite Alterola Biotech and Bionoid Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alterola Biotech position performs unexpectedly, Bionoid Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionoid Pharma will offset losses from the drop in Bionoid Pharma's long position.
The idea behind Alterola Biotech and Bionoid Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Commodity Directory
Find actively traded commodities issued by global exchanges
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account